Mounjaro (tirzepatide): As a dual-action GLP-1 and GIP receptor agonist, Mounjaro stands out, offering a comprehensive strategy for managing diabetes and effectively regulating blood sugar levels
This upregulation during pathological states suggests a potential adaptive response that might enhance sensitivity to GLP-1 agonist therapy during heart failure
TOPIRAMATE may decrease the density of bones when used over a long period
When tirzepatide delays gastric emptying, the absorption of birth control pills can become unpredictable
Bezin J, Bnard-Laribire A, Hucteau E, Tournier M, Montastruc F, Pariente A, et al
Free Radic Biol Med , 1998